Mapping C-Terminal Transactivation Domains of the Nuclear HER Family Receptor Tyrosine Kinase HER3
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Mapping C-Terminal Transactivation Domains of the Nuclear HER Family Receptor Tyrosine Kinase HER3
Authors
Keywords
-
Journal
PLoS One
Volume 8, Issue 8, Pages e71518
Publisher
Public Library of Science (PLoS)
Online
2013-08-09
DOI
10.1371/journal.pone.0071518
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Landscape of EGFR signaling network in human cancers: Biology and therapeutic response in relation to receptor subcellular locations
- (2012) Woody Han et al. CANCER LETTERS
- ErbB380kDa, a nuclear variant of the ErbB3 receptor, binds to the Cyclin D1 promoter to activate cell proliferation but is negatively controlled by p14ARF
- (2012) Laëtitia Andrique et al. CELLULAR SIGNALLING
- EGFR Nuclear Translocation Modulates DNA Repair following Cisplatin and Ionizing Radiation Treatment
- (2011) G. Liccardi et al. CANCER RESEARCH
- Toward the Prognostic Significance and Therapeutic Potential of HER3 Receptor Tyrosine Kinase in Human Colon Cancer
- (2011) A. Beji et al. CLINICAL CANCER RESEARCH
- Structure and functions of powerful transactivators: VP16, MyoD and FoxA
- (2011) Hiroyuki Hirai et al. INTERNATIONAL JOURNAL OF DEVELOPMENTAL BIOLOGY
- Nuclear Translocation of Epidermal Growth Factor Receptor by Akt-dependent Phosphorylation Enhances Breast Cancer-resistant Protein Expression in Gefitinib-resistant Cells
- (2011) Wei-Chien Huang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- A Nuclear Variant of ErbB3 Receptor Tyrosine Kinase Regulates Ezrin Distribution and Schwann Cell Myelination
- (2011) T. Adilakshmi et al. JOURNAL OF NEUROSCIENCE
- Nuclear epidermal growth factor receptor modulates cellular radio-sensitivity by regulation of chromatin access
- (2011) Klaus Dittmann et al. RADIOTHERAPY AND ONCOLOGY
- HER-3 Overexpression Is Prognostic of Reduced Breast Cancer Survival
- (2010) Connie G. Chiu et al. ANNALS OF SURGERY
- Epidermal Growth Factor Receptor cooperates with Src Family Kinases in acquired resistance to cetuximab
- (2010) Deric L. Wheeler et al. CANCER BIOLOGY & THERAPY
- HER3 Comes of Age: New Insights into Its Functions and Role in Signaling, Tumor Biology, and Cancer Therapy
- (2010) M. R. Campbell et al. CLINICAL CANCER RESEARCH
- Nuclear EGFR shuttling induced by ionizing radiation is regulated by phosphorylation at residue Thr654
- (2010) Klaus Dittmann et al. FEBS LETTERS
- Lipid raft localization of EGFR alters the response of cancer cells to the EGFR tyrosine kinase inhibitor gefitinib
- (2010) Mary E. Irwin et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Nuclear EGFR in ductal invasive breast cancer: correlation with cyclin-D1 and prognosis
- (2010) Ita Hadžisejdić et al. MODERN PATHOLOGY
- Progesterone Receptor Induces ErbB-2 Nuclear Translocation To Promote Breast Cancer Growth via a Novel Transcriptional Effect: ErbB-2 Function as a Coactivator of Stat3
- (2010) W. Beguelin et al. MOLECULAR AND CELLULAR BIOLOGY
- PAX5 is expressed in small-cell lung cancer and positively regulates c-Met transcription
- (2009) Rajani Kanteti et al. LABORATORY INVESTIGATION
- Nuclear EGFR contributes to acquired resistance to cetuximab
- (2009) C Li et al. ONCOGENE
- Structural analysis of the catalytically inactive kinase domain of the human EGF receptor 3
- (2009) N. Jura et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- All EGF(ErbB) receptors have preformed homo- and heterodimeric structures in living cells
- (2008) R.-H. Tao et al. JOURNAL OF CELL SCIENCE
- Nuclear expression of epidermal growth factor receptor is a novel prognostic value in patients with ovarian cancer
- (2008) Weiya Xia et al. MOLECULAR CARCINOGENESIS
- Mechanisms of acquired resistance to cetuximab: role of HER (ErbB) family members
- (2008) D L Wheeler et al. ONCOGENE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation